Product name: BPC‑157 + TB‑500
Type: Research blend of two peptides

Compound Composition:

• TB-500 – 10 mg
• BPC-157 – 10 mg

Research Focus:

BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide fragment derived from human gastric juice, studied for its cytoprotective and tissue-repair properties across gastrointestinal, musculoskeletal, and neurological systems[1][2]. TB-500 (Thymosin β4) is a 43-amino-acid peptide involved in cell migration, angiogenesis, and wound healing[3][4]. This blend combines both peptides for synergistic tissue-repair research applications.

Research Interest

• Experimental protocols looking at complementary healing pathways

• Musculoskeletal injury research

Scientific Interest:

• Laboratory studies on multi-pathway cellular dynamics

• Synergistic effects in tissue modeling

• Complex connective tissue research

Reconstitution:

• Reconstitute: Add 3.0 mLbacteriostatic water → ~6.67 mg/mLtotal concentration (~3.33 mg/mL of each peptide).

• Typical daily range: 250–500 mcg BPC-157 + 250–500 mcg TB-500(500–1,000 mcg total blend) once daily.

• Easy measuring: At 6.67 mg/mL total, 1 unit = 0.01 mL ≈ 66.7 mcg total (~33.3 mcg of each peptide) on a U-100 insulin syringe.

• Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); use within 14 days.

Cycle:

Standard / Gradual Approach (3 mL = ~6.67 mg/mL total)

Route: Subcutaneous injection | Frequency:Once daily

For ≤10-unit (≤0.10 mL) administrations during Weeks 1–4, consider using 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

1. Draw 3.0 mL bacteriostatic water with a sterile syringe.

2. Inject slowly down the vial wall; avoid foaming or direct stream onto the powder.

3. Gently swirl or roll until fully dissolved (do not shake).

4. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Advanced / Loading Phase (Optional)

Some protocols use a higher TB-500 loading dose during the first 2–4 weeks based on clinical monograph recommendations[5]. This schedule uses higher total blend volumes.

Route: Subcutaneous injection | Frequency:Once daily or split twice weekly for TB-500 loading

Note: Advanced protocols consume peptide supplies faster. Plan vial quantities accordingly.

IMPORTANT NOTICE:

This product is intended strictly for laboratory research. It is not intended to diagnose, treat, cure, or prevent any disease.